ABP AND THE REGULATION OF GERM CELL APOPTOSIS IN TESTIS
ABP与睾丸生殖细胞凋亡的调控
基本信息
- 批准号:6233419
- 负责人:
- 金额:$ 1.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-03-01 至 2001-06-30
- 项目状态:已结题
- 来源:
- 关键词:androgen binding protein androgen receptor apoptosis cell growth regulation cell proliferation dihydrotestosterone estradiol estrogen receptors flow cytometry gene expression genetically modified animals germ cells immunocytochemistry in situ hybridization laboratory mouse northern blottings polymerase chain reaction radioimmunoassay spermatogenesis testis testosterone western blottings
项目摘要
Spermatogenesis is an androgen-dependent process and androgen-binding
protein (ABP), a secretory product of Sertoli cells, is considered a
mediator of androgens action on the developing germ cells. However,
ABP's precise mode of action is not known. In order to understand the
functions of ABP and, in a broader sense, the role of androgens in the
control of spermatogenesis, we have studied transgenic mice expressing
high amounts of ABP. These animals show progressive abnormalities of
spermatogenesis and an eventual loss of fertility. In order to explain
this finding, we hypothesize that the chronic overproduction of ABP
changes the balance between proliferation and degeneration (apoptosis)
of germ cells by changing the steroid hormone milieu within the
seminiferous tubules. This may involve not only testosterone, but also
is biologically active intratesticular metabolites dihydrotestosterone
and estradiol. To test the above hypothesis, we propose to determine
the effects of excess ABP produced in the transgenic animals on (1)--
testicular levels of testosterone, dihydrotestosterone, estradiol, and
the androgen and estrogen receptors. Specific radioimmunoassays,
immunocytochemistry, and in situ hybridization will be used to achieve
this goal. (2)--the kinetics of germ cell proliferation and apoptosis
preceding and during the decline in spermatogenesis. Flow cytometry and
morphometric analysis will be used after specific labeling of both
proliferating and apoptotic cells. Apoptosis will be detected by in
situ end labeling of fragmented DNA and by gel electrophoresis. (3)--
the expression of genes regulating germ cell proliferation and
apoptosis. Gene expression will be analyzed before and during the
decline in spermatogenesis by immunocytochemistry, in situ
hybridization, in situ PCR, and Northern blot analysis.
These studies will lead to a better understanding of the regulation of
spermatogenesis and of some forms of male infertility; they may also
reveal potential new targets for male contraception.
精子发生是一个雄激素依赖性过程,并且与雄激素结合
蛋白质(ABP)是支持细胞的分泌产物,被认为是
雄激素对发育中生殖细胞作用的调节剂。 然而,
ABP 的精确作用方式尚不清楚。 为了了解
ABP 的功能,以及更广泛意义上的雄激素在
控制精子发生,我们研究了表达
大量 ABP。 这些动物表现出进行性异常
精子发生并最终丧失生育能力。 为了解释
这一发现,我们假设 ABP 的长期过量产生
改变增殖和退化(细胞凋亡)之间的平衡
通过改变生殖细胞内的类固醇激素环境
生精小管。 这可能不仅涉及睾酮,还涉及
是具有生物活性的睾丸内代谢物二氢睾酮
和雌二醇。 为了检验上述假设,我们建议确定
转基因动物中产生的过量 ABP 对 (1)--
睾丸激素、二氢睾酮、雌二醇和
雄激素和雌激素受体。 特异性放射免疫测定,
免疫细胞化学和原位杂交将用于实现
这个目标。 (2)--生殖细胞增殖和凋亡的动力学
在精子发生衰退之前和期间。 流式细胞仪和
在对两者进行特定标记后将使用形态测量分析
增殖和凋亡的细胞。 细胞凋亡将被检测到
片段化 DNA 的原位末端标记和凝胶电泳。 (3)--
调节生殖细胞增殖的基因的表达和
细胞凋亡。 基因表达将在实验之前和过程中进行分析
免疫细胞化学原位精子发生下降
杂交、原位 PCR 和 Northern 印迹分析。
这些研究将有助于更好地理解监管
精子发生和某些形式的男性不育症;他们也可能
揭示男性避孕的潜在新目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER PETRUSZ其他文献
PETER PETRUSZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER PETRUSZ', 18)}}的其他基金
Regulation of Gene Expression During Spermatogenesis
精子发生过程中基因表达的调控
- 批准号:
6575384 - 财政年份:2003
- 资助金额:
$ 1.69万 - 项目类别:
Regulation of Gene Expression During Spermatogenesis
精子发生过程中基因表达的调控
- 批准号:
6723750 - 财政年份:2003
- 资助金额:
$ 1.69万 - 项目类别:
ABP AND THE REGULATION OF GERM CELL APOPTOSIS IN TESTIS
ABP与睾丸生殖细胞凋亡的调控
- 批准号:
2622799 - 财政年份:1998
- 资助金额:
$ 1.69万 - 项目类别:
ABP AND THE REGULATION OF GERM CELL APOPTOSIS IN TESTIS
ABP与睾丸生殖细胞凋亡的调控
- 批准号:
2883164 - 财政年份:1998
- 资助金额:
$ 1.69万 - 项目类别:
相似海外基金
Androgen receptor: A master regulator of lipid metabolism
雄激素受体:脂质代谢的主要调节因子
- 批准号:
DP230103210 - 财政年份:2023
- 资助金额:
$ 1.69万 - 项目类别:
Discovery Projects
Regulation of androgen receptor signaling in prostate cancer by protein arginine methylation
通过蛋白质精氨酸甲基化调节前列腺癌中的雄激素受体信号传导
- 批准号:
10584689 - 财政年份:2023
- 资助金额:
$ 1.69万 - 项目类别:
Structural and functional analysis of a novel class of androgen receptor antagonists
一类新型雄激素受体拮抗剂的结构和功能分析
- 批准号:
10650956 - 财政年份:2023
- 资助金额:
$ 1.69万 - 项目类别:
Role of the Androgen Receptor in Insulin Secretion in the Male
雄激素受体在男性胰岛素分泌中的作用
- 批准号:
10488954 - 财政年份:2023
- 资助金额:
$ 1.69万 - 项目类别:
Targeting tumor cell macrophage lipid interactions to overcome resistance to androgen receptor targeted therapy
靶向肿瘤细胞巨噬细胞脂质相互作用以克服对雄激素受体靶向治疗的耐药性
- 批准号:
10651105 - 财政年份:2023
- 资助金额:
$ 1.69万 - 项目类别:
Preclinical development of ONCT-505, an Androgen Receptor Antagonist and Degrader, as new potential therapeutic for Kennedy's Disease
ONCT-505(一种雄激素受体拮抗剂和降解剂)的临床前开发,作为肯尼迪病的新潜在治疗方法
- 批准号:
10603636 - 财政年份:2023
- 资助金额:
$ 1.69万 - 项目类别:
Proliferating cell nuclear antigen in regulation of androgen receptor signalings in castration-resistant prostate cancer cells
增殖细胞核抗原对去势抵抗性前列腺癌细胞雄激素受体信号传导的调节
- 批准号:
10544062 - 财政年份:2022
- 资助金额:
$ 1.69万 - 项目类别:
Effects of androgen receptor (AR) signaling on CD4+ T cell metabolism during airway inflammation
气道炎症期间雄激素受体 (AR) 信号对 CD4 T 细胞代谢的影响
- 批准号:
10534943 - 财政年份:2022
- 资助金额:
$ 1.69万 - 项目类别:
TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE
标题:使用雄激素受体抑制剂阿帕鲁胺进行膀胱癌化学预防
- 批准号:
10677989 - 财政年份:2022
- 资助金额:
$ 1.69万 - 项目类别:














{{item.name}}会员




